Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Astringents
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Astringents
Tree Number(s)
D27.505.696.207
D27.505.954.444.100
Unique ID
D001252
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D001252
Scope Note
Agents, usually topical, that cause the contraction of tissues for the control of bleeding or secretions.
Entry Term(s)
Astringent
Astringent Effect
Astringent Effects
NLM Classification #
QV 65
Public MeSH Note
ANTIPERSPIRANTS was see ASTRINGENTS 1985-94
Online Note
use ASTRINGENTS to search ANTIPERSPIRANTS 1985-94
History Note
ANTIPERSPIRANTS was see ASTRINGENTS 1985-94
Date Established
1960/01/01
Date of Entry
1999/01/01
Revision Date
2020/05/27
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
agonists (AG)
analysis (AN)
antagonists & inhibitors (AI)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Abuse-Deterrent Formulations [D27.505.696.034]
Antipyretics [D27.505.696.068]
Antispermatogenic Agents [D27.505.696.138]
Astringents [D27.505.696.207]
Bone Density Conservation Agents [D27.505.696.242]
Calcium-Regulating Hormones and Agents [D27.505.696.260]
Central Nervous System Depressants [D27.505.696.277]
Central Nervous System Stimulants [D27.505.696.282]
Cerumenolytic Agents [D27.505.696.305]
Emetics [D27.505.696.329]
Endocrine Disruptors [D27.505.696.353]
Galactogogues [D27.505.696.365]
Growth Substances [D27.505.696.377]
Hallucinogens [D27.505.696.388]
Hormones, Hormone Substitutes, and Hormone Antagonists [D27.505.696.399]
Hypoglycemic Agents [D27.505.696.422]
Immunologic Factors [D27.505.696.477]
Micronutrients [D27.505.696.494]
Muscle Relaxants, Central [D27.505.696.510]
Narcotic Antagonists [D27.505.696.543]
Natriuretic Agents [D27.505.696.560]
Neurotransmitter Agents [D27.505.696.577]
Performance-Enhancing Substances [D27.505.696.620]
Peripheral Nervous System Agents [D27.505.696.663]
Protective Agents [D27.505.696.706]
Reproductive Control Agents [D27.505.696.875]
Secretagogues [D27.505.696.937]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Dermatologic Agents [D27.505.954.444]
Antipruritics [D27.505.954.444.075]
Astringents [D27.505.954.444.100]
Emollients [D27.505.954.444.200]
Keratolytic Agents [D27.505.954.444.400]
Photosensitizing Agents [D27.505.954.444.600]
Sunscreening Agents [D27.505.954.444.695]
Expand All
Collapse All
Astringents
Preferred
Concept UI
M0001889
Scope Note
Agents, usually topical, that cause the contraction of tissues for the control of bleeding or secretions.
Terms
Astringents
Preferred Term
Term UI
T003749
Date
01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1966)
Astringent
Term UI
T000997765
Date
11/19/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
Astringent Effect
Related
Concept UI
M0556124
Terms
Astringent Effect
Preferred Term
Term UI
T787904
Date
03/29/2011
LexicalTag
NON
ThesaurusID
NLM (2012)
Astringent Effects
Term UI
T787905
Date
03/29/2011
LexicalTag
NON
ThesaurusID
NLM (2012)
page delivered in 0.165s